Skip to main content

and
  1. No Access

    Article

    Severe cutaneous adverse reactions

    Severe cutaneous adverse reactions (SCARs), which include Stevens–Johnson syndrome and toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (also known as drug-induced hypersensiti...

    Shuen-Iu Hung, Maja Mockenhaupt, Kimberly G. Blumenthal in Nature Reviews Disease Primers (2024)

  2. No Access

    Article

    Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients

    Sarcoidosis is a systemic disease that affects the skin in about 25% of patients. The treatment of cutaneous sarcoidosis is guided by the extent of lesions, associated symptoms and organ involvement.

    Elisabeth Cohen, Coralie Lheure, Saskia Ingen-Housz-Oro in European Journal of Dermatology (2023)

  3. Article

    Open Access

    Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management

    Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious and rare diseases, most often drug-induced, and their incidence has been estimated at 6 cases/million/year in France. SJS and TEN...

    Dhyna Thorel, Saskia Ingen-Housz-Oro, Daniel Benaïm in Orphanet Journal of Rare Diseases (2023)

  4. No Access

    Article

    IgA vasculitis with underlying monoclonal IgA gammopathy: innovative therapeutic approach targeting plasma cells. A case series

    There is currently no evidence of the possible benefit of plasma cell–targeting therapies (PCTT) in immunoglobulin A (IgA) monoclonal gammopathy (MG) associated with IgA vasculitis (IgAV). We report the outcom...

    Antoine Hankard, Saskia Ingen-Housz-Oro, Khalil El Karoui in Clinical Rheumatology (2022)

  5. No Access

    Chapter

    Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

    Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are manifestations of a drug-induced mucocutaneous epithelial necrolysis syndrome. The two entities represent either end of a severity spectr...

    Saskia Ingen-Housz-Oro, Tu-anh Duong, Olivier Chosidow in Drug Eruptions (2022)

  6. Article

    Open Access

    Clinical relevance of interdental papilla biopsy in chronic erosive gingivitis (desquamative gingivitis): retrospective bicentric study of 148 specimens

    Chronic erosive gingivitis, also called desquamative gingivitis, defines a clinical picture that can be generated by several inflammatory and immune diseases. Pathology is therefore essential for the different...

    Frédérick Gaultier, Anne-laure Ejeil, Sébastien Jungo in BMC Oral Health (2021)

  7. No Access

    Article

    Clinical and histological features of fixed drug eruption: a single-centre series of 73 cases with comparison between bullous and non-bullous forms

    The clinical and pathological aspects of fixed drug eruption (FDE) have been described based on a few case series.

    Emilie Perron, Alice Viarnaud, Lea Marciano in European Journal of Dermatology (2021)

  8. No Access

    Chapter

    New or Unusual Skin Manifestations in Monoclonal Gammopathies

    Skin manifestations associated with monoclonal gammopathy (MG) are common and can present with various clinical and pathological aspects. They can be the first clinical manifestation leading to the diagnosis of.....

    Nicolas Ortonne, Saskia Ingen-Housz-Oro in New and Emerging Entities in Dermatology a… (2021)

  9. No Access

    Article

    Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge

    Sophie Lalevee, Nicolas Ortonne, Claire Hotz in European Journal of Dermatology (2018)

  10. Article

    Open Access

    Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)

    Epidermal necrolysis (EN) encompasses Stevens-Johnson syndrome (SJS, < 10% of the skin affected), Lyell syndrome (toxic epidermal necrolysis, TEN, with ≥30% of the skin affected) and an overlap syndrome (10 to...

    Saskia Ingen-Housz-Oro, Tu-Anh Duong, Benoit Bensaid in Orphanet Journal of Rare Diseases (2018)

  11. No Access

    Article

    Dermatitis herpetiformis and bone mineral density: analysis of a French cohort of 53 patients

    The characteristics of patients with dermatitis herpetiformis (DH) in France is poorly documented. Furthermore, the risk of fractures and bone mineral density (BMD) in DH remain under-described, and recommenda...

    Coralie Lheure, Saskia Ingen-Housz-Oro, Sandra Guignard in European Journal of Dermatology (2017)

  12. No Access

    Article

    Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients

    Hypersensitivity reactions (HSR) to pegylated liposomal doxorubicin (PLD; Caelyx®) have been reported, and symptoms usually resolve with drug withdrawal. However, the risk of relapse of severe HSR and prevention ...

    Saskia Ingen-Housz-Oro, Anne Pham-Ledard, Pauline Brice in European Journal of Dermatology (2017)